Request availability and a quotation for your required quantity and destination.
| Product | Semaglutide 1 mg - Generic Ozempic Pen |
|---|---|
| Categories | Weight Loss |
| Availability | Confirmed on enquiry |
Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.
Composition and product identification: Listed semaglutide 1 mg injection pen. The asserted generic status, exact device, manufacturer, concentration and regulatory approval have not been verified.
Semaglutide is a GLP-1 receptor agonist used in specified approved products for type 2 diabetes and, under different labels or formulations, weight management. Indications and dosing differ by product; a catalogue title does not establish therapeutic equivalence to Ozempic.
Semaglutide can cause gastrointestinal adverse effects and dehydration. Pancreatitis, gallbladder disease, severe gastrointestinal reactions, and hypoglycaemia with some other diabetes medicines are concerns. Some semaglutide labels warn against use with personal or family history of medullary thyroid carcinoma or MEN2. Prescription and product authenticity are essential.
Semaglutide and tirzepatide comparison. Verify that related information applies to this exact formulation; links do not establish product approval.
Any enquiry requires confirmation of the actual ingredients, manufacturer, approval status, prescription or veterinary authorization and destination-country import regulations. This description is educational and has not been independently medically reviewed.